Literature DB >> 2516317

Engineering subtilisin BPN' for site-specific proteolysis.

P Carter1, B Nilsson, J P Burnier, D Burdick, J A Wells.   

Abstract

A combination of protein engineering and substrate optimization was used to create variants of the serine protease, subtilisin BPN', which efficiently and specifically cleave a designed target sequence in a fusion protein. The broad substrate specificity of wild-type subtilisin BPN' is greatly restricted by substitution of the catalytic histidine-containing of the catalytic histidine 64 with alanine (H64A) so that certain histidine-containing substrates are preferentially hydrolysed (Carter, P., Wells, J.A. Science 237:394-399, 1987). The catalytic efficiency, (kcat/Km), of this H64A variant was increased almost 20-fold by judicious choice of substrate and by installing three additional mutations which increase the activity of wild-type subtilisin. The most favorable substrate sequence identified was introduced as a linker in a fusion protein between a synthetic IgG binding domain of Staphylococcus aureus protein A and Escherichia coli alkaline phosphatase. The fusion protein (affinity purified on an IgG column) was cleaved by the prototype H64A enzyme and its improved variant, efficiently and exclusively at the target site, to liberate an alkaline phosphatase product of the expected size and N-terminal sequence. Several features of H64A variants of subtilisin make them attractive for site-specific proteolysis of fusion proteins: they have exquisite substrate specificity on the N-terminal side of the cleavage site and yet are broadly specific on the C-terminal side; they can be produced in large quantities and remain highly active even in the presence of detergents, reductants (modest concentrations), protease inhibitors, at high temperatures, or when specifically immobilized on a solid support.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2516317     DOI: 10.1002/prot.340060306

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

Review 1.  Substrate-assisted catalysis: molecular basis and biological significance.

Authors:  W Dall'Acqua; P Carter
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

2.  Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.

Authors:  Allan L Berger; Mutsuhiro Ikuma; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

3.  Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1.

Authors:  K L Fisher; J Lu; L Riddle; K J Kim; L G Presta; S C Bodary
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

Review 4.  Structural basis of substrate specificity in the serine proteases.

Authors:  J J Perona; C S Craik
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

5.  Engineering multiple properties of a protein by combinatorial mutagenesis.

Authors:  W S Sandberg; T C Terwilliger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

6.  Expression and purification of recombinant proteins by fusion to maltose-binding protein.

Authors:  P Riggs
Journal:  Mol Biotechnol       Date:  2000-05       Impact factor: 2.695

7.  Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.

Authors:  G L Francis; S E Aplin; S J Milner; K A McNeil; F J Ballard; J C Wallace
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

8.  An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I.

Authors:  G Forsberg; B Baastrup; H Rondahl; E Holmgren; G Pohl; M Hartmanis; M Lake
Journal:  J Protein Chem       Date:  1992-04

9.  Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone.

Authors:  G Forsberg; M Brobjer; E Holmgren; K Bergdahl; P Persson; K M Gautvik; M Hartmanis
Journal:  J Protein Chem       Date:  1991-10

10.  The EVB as a quantitative tool for formulating simulations and analyzing biological and chemical reactions.

Authors:  Shina C L Kamerlin; Arieh Warshel
Journal:  Faraday Discuss       Date:  2010       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.